Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Neurologic complications of influenza.
Cyclical suicidal ideation following natalizumab infusion for multiple sclerosis.
Antidepressant activity of fingolimod in mice.
Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
No Help from Dalfampridine in MS-Related Optic Neuritis
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Glycans of myelin proteins.
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
NMO spectrum presenting as partial myelitis.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
B cell exchange across the blood-brain barrier in multiple sclerosis.
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Erythrocyte membrane Fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
Multiple Sclerosis Disease Progression and Paradichlorobenzene: A Tale of Mothballs and Toilet Cleaner.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.

Pages